Camber Capital Management’s Merck MRK Stock Holding History

Camber Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,500,000	Closed	-$129M	–	45
2022 Q3	$129M	Buy	+1,500,000	New	+$134M	3.96%	8
2022 Q1	–	Sell	-2,000,000	Closed	-$153M	–	42
2021 Q4	$153M	Hold	2,000,000	–	–	5.27%	7
2021 Q3	$150M	Hold	2,000,000	–	–	4.63%	6
2021 Q2	$156M	Buy	+2,000,000	New	+$149M	5.24%	4

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Camber Capital Management's MRK Position: Q2 2025 in Review

Camber Capital Management opened a new position in Merck (MRK) in Q2 2025: 500,000 shares worth $39.6M. The stake represents 3.72% of the portfolio and ranks #9 among its holdings. This is a return to the name: Camber Capital Management previously reported a position in MRK as recently as Q1 2022.

Camber Capital Management first reported a position in MRK in Q4 2013 and has held it in 7 quarters since. The position peaked at $192M in Q4 2021. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

Camber Capital Management held 500,000 shares of Merck worth $39.6M as of Q2 2025.
Merck was a new Camber Capital Management position in Q2 2025.
Merck made up 3.72% of Camber Capital Management's portfolio in Q2 2025, its #9 holding.
Camber Capital Management first reported a position in Merck in Q4 2013 and has held it in 7 quarters since.
Camber Capital Management's Merck position peaked at $192M in Q4 2021.
3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Camber Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.